ReviewArteriosclerosis, thrombosis, and vascular biology2026
Fluctuations in Sleep Duration and Timing and Cardiometabolic Risk.
Review in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Sleep behavior has emerged as an important determinant of cardiometabolic health. However, to date, much attention has focused on sleep duration with accumulating evidence resulting in leading medical organizations to include adequate sleep duration in their recommendations for disease risk prevention and health promotion. However, sleep is a multidimensional construct that extends beyond sleep duration and includes factors related to the variability of duration but also to the regularity in its timing across days. These concepts, termed sleep duration variability (day-to-day differences in sleep amounts) and sleep timing regularity (day-to-day differences in sleep timing), can influence the circadian system and have independent health effects beyond sleep duration per se. Here, we assess the literature evaluating the association of fluctuations in sleep behaviors over time and cardiometabolic risk factors and their potential implications for chronic disease development. We conclude that large-scale population-based studies support an adverse relation between fluctuations in sleep behaviors and cardiovascular disease risk markers, but caution that causality should be evaluated in clinical intervention studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.